A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT)-Reference-Cited by-同舟云学术

A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT)

Published:2018-05-14 Issue:4 Volume:179 Page:836-843
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Kim Y.C.¹,Yang J.Y.¹,Yoon J.S.¹,Jo S.J.²^ORCID,Ahn H.H.³,Song K.-H.⁴^ORCID,Lee D.-Y.⁵,Chung K.-Y.⁶,Won Y.-H.⁷,Kim I.-H.⁸^ORCID

Affiliation:

1. Department of Dermatology; Ajou University School of Medicine; Suwon Republic of Korea

2. Department of Dermatology; Seoul National University College of Medicine; Seoul Republic of Korea

3. Department of Dermatology; Korea University Anam Hospital; Korea University College of Medicine; Seoul Republic of Korea

4. Department of Dermatology; Dong-A University College of Medicine; Busan Republic of Korea

5. Department of Dermatology; Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Republic of Korea

6. Department of Dermatology; Severance Hospital; Cutaneous Biology Research Institute; Yonsei University College of Medicine; Seoul Republic of Korea

7. Department of Dermatology; Chonnam National University Medical School; Gwangju Republic of Korea

8. Department of Dermatology; Korea University Ansan Hospital; Korea University College of Medicine; 123 Jeokgeum-ro, Danwon-gu Ansan 15355 Republic of Korea

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.16368/fullpdf

Reference20 articles.

1. Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006;Kim;J Korean Med Sci,2010

2. The relationship between solar keratoses and squamous cell carcinomas among Japanese;Takemiya;J Dermatol,1990

3. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - short version;Werner;J Eur Acad Dermatol Venereol,2015

4. Development of a treatment algorithm for actinic keratoses: a European Consensus;Stockfleth;Eur J Dermatol,2008

5. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response;Rosen;J Am Acad Dermatol,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study;Acta Dermato-Venereologica;2023-10-24

2. 5‐ALA loaded self‐adhesive patch‐PDT is effective and safe in the treatment of actinic keratoses on hands and arms;Experimental Dermatology;2022-05-23

3. Bioprospection and Clinical Investigations of Immunomodulatory Molecules;Plants and Phytomolecules for Immunomodulation;2022

4. Safety of topical interventions for the treatment of actinic keratosis;Expert Opinion on Drug Safety;2021-04-27

5. A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials;Journal of Clinical Medicine;2020-07-15